Results 101 to 110 of about 256,850 (180)

FastNano Liquid: An Automated Platform for Small‐Angle X‐ray Scattering‐Based Materials Discovery

Advanced Engineering Materials, Volume 28, Issue 20, 21 October 2026.
We present FastNano Liquid, an automated small‐ and wide‐angle X‐ray scattering platform for the combined synthesis and characterization of (nano)materials. The platform is coupled to varied reactor workflows for both in situ studies of reaction kinetics and ex situ screening of synthesis conditions to support machine learning‐guided exploration ...
Pierre‐Baptiste Flandrin, Émeline Cournède, Jens Krarup, Michael Lesa, Foyzul Hasan, Amandine Séné, Arnaud Lahouati, David Benhaiem, Jérémie‐Luc Sanchez, Simon Delacroix, Thierry Gacoin, Fabienne Testard, Damien Faivre, David Carriere, Corinne Chevallard, Olivier Taché, Mark A. Levenstein   +16 more
wiley   +1 more source

Telluroesters: Synthesis and Reactivity in Nucleophilic Acyl Substitution

Advanced Synthesis &Catalysis, Volume 368, Issue 20, 16 October 2026.
A simple and general protocol to access telluroesters, a versatile class of organotellurium compounds serving as precursors of acyl radicals, is described. Their previously unexplored reactivity in nucleophilic acyl substitutions enables the efficient transfer of acyl moieties onto a broad range of nucleophiles under mild conditions.
Antonella Capperucci, Laurent Levani, Vittoria Tavarnesi, Damiano Tanini   +3 more
wiley   +1 more source

Lanthanum carbonate inhibits intestinal oxalate absorption and prevents nephrocalcinosis after oxalate loading in rats

, 2013
: Purpose: Increased intestinal oxalate absorption leads to increased urinary oxalate excretion (secondary hyperoxaluria) and calcium oxalate crystal formation, contributing to nephrocalcinosis/lithiasis.
Hoppe, Bernd, Robijn, Stef, d' Haese, Patrick C., Verhulst, Anja, Vervaet, Benjamin A.   +4 more
core   +1 more source

Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis. [PDF]

Ren Fail, 2021
Zhao L, Liu A, Xu G.
europepmc   +1 more source

Rare Earth Metal Ion-Associates in Ln³⁺—CO₃²⁻—H₂O System

Metals
This study focused on the nature of rare earth metal complex compounds that can form during the carbonate–alkaline processing of industrial waste materials, such as phosphogypsum and red mud, at 70–100 °C and 1–10 atm. Experimental findings revealed that
Tatiana Litvinova, Stepan Gerasev, Vasiliy Sergeev, Egor Lidanovskiy   +3 more
doaj   +1 more source

Effect of low-dose lanthanum carbonate on calcium and phosphorus metabolism in Asian Patients with end-stage renal disease, maintenance hemodialysis and hyperphosphatemia. [PDF]

Afr Health Sci, 2022
Cui X, Jiang S, Liu L, Tang X, Chen Y.
europepmc   +1 more source

Lanthanum carbonate - A first line phosphate binder?

, 2007
Hyperphosphatemia is associated with increased morbidity and mortality in dialysis patients. Oral phosphate binders are necessary to control serum phosphate in patients eating a normal diet and undergoing peritoneal dialysis or thrice weekly hemodialysis.
De Freitas, Declan, Donne, Rosemary L., Hutchison, Alastair, Hutchison, Alastair J.   +3 more
core   +1 more source

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease. [PDF]

Ther Clin Risk Manag, 2021
Makowka A, Nowicki M.
europepmc   +1 more source

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: A 4-week, dose-finding, open-label study with lanthanum carbonate

, 2004
Background. The majority of patients with end-stage renal disease on dialysis are hyperphosphataemic. Lanthanum carbonate has been shown to be a highly effective phosphate binder in pre-clinical studies.
Al-Baaj, Fouad, Hutchison, Alastair J., Speake, Mary   +2 more
core   +1 more source

Lanthanum deposition disease as a cause of gastrointestinal bleeding in a dialysis patient: a case report

Renal Replacement Therapy
Background Lanthanum carbonate (LC) is a calcium-free phosphate binder widely used in patients with chronic kidney disease, including those undergoing dialysis.
Yoshitaka Furuto, Hirotomo Koda, Daiki Yoshino, Sayako Ikeda, Akio Namikawa, Dai Sato, Teppei Morikawa, Yuko Shibuya   +7 more
doaj   +1 more source